PBT anti-tumor activity was accompanied by an increase in activated CD8+ T-cells and a decrease in immunosuppressive tumor infiltrating cells including Gr-1+CD11b+ myeloid derived suppressor cells (MDSCs), CD4+CD25+ Tregs, and CD206+F4/80+ M2 macrophages. The gene discussed is CD8A; the disease is neoplasm.